Metachronous malignancies after response to checkpoint inhibition

Mirjam A. de Visser*, Francois B. Verschaeve, Lot A. Devriese, Bart Neyns, Karijn P.M. Suijkerbuijk

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)99-101
Number of pages3
JournalEuropean Journal of Cancer
Volume174
Early online date17 Aug 2022
DOIs
Publication statusPublished - Oct 2022

Keywords

  • Humans
  • Neoplasms, Multiple Primary
  • Neoplasms, Second Primary/drug therapy

Cite this